SOPHIA KOLODZINSKI
ASSOCIATE
Sophia has a primary focus on investor relations, including marketing and finance, supporting Bonaccord teams on all aspects of corporate communications and fundraising.
Prior to joining Bonaccord, Sophia was a Senior Biotechnology Investor Relations Analyst at Stern Investor Relations, a Precision Medicine Group owned company.
Sophia earned a Bachelor of Arts in Political Science and Communications with a focus in Entrepreneurship from the University of Michigan.